Lilly is testing bimagrumab alone and in combination with Novo's Wegovy -- a mid-stage trial begun before the acquisition -- ...
Some doctors say drugs that improve muscle mass could benefit older or infirm people at greater risk of falls and fractures.
Current weight-loss methods such as lifestyle changes, surgery, and popular therapies like Novo Nordisk's Wegovy and Eli ...
Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback